Observational studies of salvage treatment for persistent bacteremia: Beware of survivor treatment selection bias

Clinical Infectious Diseases

Volumn 49, Issue 12, 2009, Pages 1960-

  Tattevin, Pierre ^a   Uhel, Fabrice ^a   Fily, Fabien ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; LINEZOLID; VANCOMYCIN;

BACTEREMIA; DISEASE DURATION; DRUG EFFICACY; HUMAN; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SALVAGE THERAPY; SURVIVAL; TREATMENT OUTCOME;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG THERAPY, COMBINATION; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OXAZOLIDINONES; SALVAGE THERAPY; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 72049124271     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/648500     Document Type: Letter

References (4)

1. Jang HC, Kim SH, Kim KH, et al. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin Infect Dis 2009; 49:395-401.
2. GlesbyMJ,HooverDR.Survivortreatmentselectionbiasinobservationalstudies: examplesfromtheAIDSliterature.AnnInternMed1996;124:999-1005.(Pubitemid28357058)
3. van Walraven C, Davis D, Forster AJ, Wells GA. Time-dependent bias was common in survival analyses published in leading clinical journals. J Clin Epidemiol 2004; 57:672-682
4. Austin PC, Mamdani MM, van Walraven C, Tu JV. Quantifying the impact of survivor treatment bias in observational studies. J Eval Clin Pract 2006; 12:601-612